RxDoctor Payments Data

Robert Marsh

Family Medicine · Minnetonka, MNNPI 1659428019

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $298,200 of the $300,180 with a category attached, or 99.3%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 88.4% of it on its own, with 2 other manufacturers making up the rest. Among family medicine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$300,180in general payments, 2019–2025

Across 183 payments — averaging $1640.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$265K
  • Shire North American Group Inc$35K
  • Zimmer Biomet$15

What the payments were for

  • Consulting fees$298,20099%
  • Travel & lodging$1,9661%
  • Food & beverage$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$300,180 in reported general payments places this provider in the 95th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Other family medicine in Minnetonka

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →